Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Brey

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Arizona Medicine|May 1, 1981
Lung toxicity resulting from exposure to nitrogen dioxide: a possible occurrence due to Titan Missle accidentsR L Brey, J J Seidenfeld
Clinical and Experimental Rheumatology|September 1, 1992
Antiphospholipid antibodies and complement activation in patients with cerebral ischemiaW D Davis, R L Brey
Lupus|January 1, 1997
Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndromeR L Brey, M K Carolin
Stroke|October 1, 1996
Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutationR L Brey, B M Coull
Lupus|October 1, 1996
Neurological aspects of antiphospholipid antibody syndromeS R Levine, R L Brey
Clinical Neurology and Neurosurgery|December 1, 1993
Soluble terminal complement components in human myasthenia gravisR J Barohn, R L Brey
Stroke|February 1, 1992
Antiphospholipid antibodies: origin, specificity, and mechanism of actionR L Brey, B M Coull
Lupus|October 1, 1996
Treatment of neurologic complications of antiphospholipid antibody syndromeR L Brey, S R Levine
Seminars in Neurology|December 1, 1991
Antiphospholipid antibodies and ischemic cerebrovascular diseaseS R Levine, R L Brey
Journal of Clinical Neuro-Ophthalmology|December 1, 1985
Neuromyelitis optica: two new cases and review of the literatureR H Whitham, R L Brey
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Arizona Medicine|May 1, 1981
Lung toxicity resulting from exposure to nitrogen dioxide: a possible occurrence due to Titan Missle accidentsR L Brey, J J Seidenfeld
Clinical and Experimental Rheumatology|September 1, 1992
Antiphospholipid antibodies and complement activation in patients with cerebral ischemiaW D Davis, R L Brey
Lupus|January 1, 1997
Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndromeR L Brey, M K Carolin
Stroke|October 1, 1996
Cerebral venous thrombosis. Role of activated protein C resistance and factor V gene mutationR L Brey, B M Coull
Lupus|October 1, 1996
Neurological aspects of antiphospholipid antibody syndromeS R Levine, R L Brey
Clinical Neurology and Neurosurgery|December 1, 1993
Soluble terminal complement components in human myasthenia gravisR J Barohn, R L Brey
Stroke|February 1, 1992
Antiphospholipid antibodies: origin, specificity, and mechanism of actionR L Brey, B M Coull
Lupus|October 1, 1996
Treatment of neurologic complications of antiphospholipid antibody syndromeR L Brey, S R Levine
Seminars in Neurology|December 1, 1991
Antiphospholipid antibodies and ischemic cerebrovascular diseaseS R Levine, R L Brey
Journal of Clinical Neuro-Ophthalmology|December 1, 1985
Neuromyelitis optica: two new cases and review of the literatureR H Whitham, R L Brey
Pageof 6